Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms – Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer.

Webcast ImageWebcast - Live
Juno Therapeutics ASH 2016 Webcast
December 05, 2016 at 11:30 p.m. ET
Juno Therapeutics ASH 2016 Webcast
Monday, December 5, 2016 11:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Juno Therapeutics Conference Call
November 23, 2016 at 5:30 a.m. PT
Juno Therapeutics Conference Call
Wednesday, November 23, 2016 5:30 a.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Replay
Q3 2016 Juno Therapeutics Earnings Conference Call
November 09, 2016 at 2:00 p.m. PT
Q3 2016 Juno Therapeutics Earnings Conference Call
Wednesday, November 9, 2016 2:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent News

DateTitle 
Dec. 03, 2016Juno Therapeutics Announces Complete Response and Corresponding Early Survival Data for JCAR014 in Patients with Ibrutinib-Refractory CLLPrinter Friendly Version
Nov. 23, 2016Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical HoldPrinter Friendly Version
Nov. 09, 2016Juno Therapeutics Reports Third Quarter 2016 Financial ResultsPrinter Friendly Version
Nov. 03, 2016Juno Therapeutics to Highlight CAR T Advances in B-cell Malignancies at ASH 2016Printer Friendly Version

Upcoming Events

DateTitle
Dec. 05, 2016
11:30 p.m. ET
Juno Therapeutics ASH 2016 Webcast

Past Events

DateTitle
11/23/16 5:30 a.m. PT
Juno Therapeutics Conference Call
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
JUNO (Common Stock)
ExchangeNASDAQ
Price$21.26
Change Stock is Up 0.83 (4.06%)
Volume1,376,083
Data as of Dec. 05, 2016 11:12 a.m. ET